Search research articles
Contact Us
Filters
Showing results (201-210 of 221) with videos related to
Page
of 23
Sort By:
European Urology
|
May 18, 2017
A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies
Melvin L K Chua, Winnie Lo, Melania Pintilie, et al.
Nature Communications
|
December 16, 2025
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer
Soumyajit Roy, Yilun Sun, Maha Hussain, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2025
The Landscape of Prostate Tumour Methylation
Jaron Arbet, Takafumi N Yamaguchi, Yu-Jia Shiah, et al.
Cancer Discovery
|
June 17, 2026
The Landscape of Prostate Tumour Methylation
Jaron Arbet, Takafumi N Yamaguchi, Yu-Jia Shiah, et al.
European Urology
|
December 9, 2020
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer
Neil K Jairath, Alan Dal Pra, Randy Vince, et al.
Nature Genetics
|
September 3, 2024
In vivo CRISPR screens identify a dual function of MEN1 in regulating tumor-microenvironment interactions
Peiran Su, Yin Liu, Tianyi Chen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 3, 2023
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus
Simon K B Spohn, Cédric Draulans, Amar U Kishan, et al.
Nature Communications
|
January 19, 2019
ONECUT2 is a driver of neuroendocrine prostate cancer
Haiyang Guo, Xinpei Ci, Musaddeque Ahmed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2025
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial
Jarey H Wang, Alexander D Sherry, Soha Bazyar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2022
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
Matthew P Deek, Kim Van der Eecken, Philip Sutera, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 221) with videos related to
Sort By:
Page
of 23
European Urology
|
May 18, 2017
A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies
Melvin L K Chua, Winnie Lo, Melania Pintilie, et al.
Nature Communications
|
December 16, 2025
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer
Soumyajit Roy, Yilun Sun, Maha Hussain, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2025
The Landscape of Prostate Tumour Methylation
Jaron Arbet, Takafumi N Yamaguchi, Yu-Jia Shiah, et al.
Cancer Discovery
|
June 17, 2026
The Landscape of Prostate Tumour Methylation
Jaron Arbet, Takafumi N Yamaguchi, Yu-Jia Shiah, et al.
European Urology
|
December 9, 2020
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer
Neil K Jairath, Alan Dal Pra, Randy Vince, et al.
Nature Genetics
|
September 3, 2024
In vivo CRISPR screens identify a dual function of MEN1 in regulating tumor-microenvironment interactions
Peiran Su, Yin Liu, Tianyi Chen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 3, 2023
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus
Simon K B Spohn, Cédric Draulans, Amar U Kishan, et al.
Nature Communications
|
January 19, 2019
ONECUT2 is a driver of neuroendocrine prostate cancer
Haiyang Guo, Xinpei Ci, Musaddeque Ahmed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2025
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial
Jarey H Wang, Alexander D Sherry, Soha Bazyar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2022
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
Matthew P Deek, Kim Van der Eecken, Philip Sutera, et al.
Page
of 23